Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations

Abstract Objective: To investigate the performance of a novel assay for N-terminal pro-brain natriuretic peptide (NT-proBNP) in diagnosing heart failure in various randomly selected general and high risk community populations. Design: Community cohort study (substudy of the echocardiographic heart of England screening study). Setting: Four randomly selected general practices in the West Midlands of England. Participants: 591 randomly sampled patients over the age of 45, stratified for age and socioeconomic status and falling into four cohorts (general population, patients with an existing clinical label of heart failure, patients prescribed diuretics, and patients deemed at high risk of heart failure). Main outcome measure: Sensitivity, specificity, positive and negative predictive values, likelihood ratios, and area under receiver operating characteristic curve for NT-proBNP assay in the diagnosis of heart failure. Results: For NT-proBNP in the diagnosis of heart failure in the general population (population screen), a level of >36 pmol/l had a sensitivity of 100%, a specificity of 70%, a positive predictive value of 7%, a negative predictive value of 100%, and an area under the receiver operating characteristic curve of 0.92 (95% confidence interval 0.82 to 1.0). Similar negative predictive values were found for patients from the three other populations screened. Conclusions: This NT-proBNP assay seems to have value in the diagnosis of heart failure in the community. High negative predictive values indicate that the assay's chief use would be to rule out heart failure in patients with suspected heart failure with normal concentrations of NT-proBNP. Positive results may identify patients who need cardiac imaging.

[1]  R. Gillum,et al.  Epidemiology of heart failure in the United States. , 1993, American heart journal.

[2]  H. Hense,et al.  Prevalence of left ventricular dysfunction in the general population , 1996 .

[3]  D. Levy,et al.  Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects , 1993, Circulation.

[4]  Mark A. Hlatky,et al.  Guidelines for the Evaluation and Management of Heart Failure Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure) , 1995 .

[5]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[6]  W. Klein,et al.  Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy. , 1999, European heart journal.

[7]  J. McMurray,et al.  Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care , 1998, BMJ.

[8]  G. Bonsel,et al.  Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. , 1994, American journal of public health.

[9]  L Irwig,et al.  Meta-analysis of Pap test accuracy. , 1995, American journal of epidemiology.

[10]  R. Lancashire,et al.  Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study , 2001, The Lancet.

[11]  J. Eisenberg.  Agency for Health Care Policy and Research. , 1999, Medical care.

[12]  D. Fassbender,et al.  Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: identification of the target vessel by myocardial contrast echocardiography , 1998 .

[13]  R. Doughty,et al.  Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment , 1997, Clinical endocrinology.

[14]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[15]  J. McMurray,et al.  Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction , 1996, BMJ.

[16]  Scott B. Cantor,et al.  COLPOSCOPY FOR THE DIAGNOSIS OF SQUAMOUS INTRAEPITHELIAL LESIONS: A META‐ANALYSIS , 1998, Obstetrics and gynecology.

[17]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[18]  R. Hobbs.  Can heart failure be diagnosed in primary care? , 2000, BMJ : British Medical Journal.

[19]  J A Swets,et al.  Enhancing and Evaluating Diagnostic Accuracy , 1991, Medical decision making : an international journal of the Society for Medical Decision Making.

[20]  M. Landray,et al.  Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study , 2000, BMJ : British Medical Journal.

[21]  M. Mikus,et al.  Accuracy of electrocardiogram reading by family practice residents. , 2000, Family medicine.

[22]  F. Hobbs.  Primary care physicians: Champions of or an impediment to optimal care of the patient with heart failure? , 1999, European journal of heart failure.

[23]  H. Dargie,et al.  The Cardiac Insufficiency Bisoprolol Study II , 1999, The Lancet.

[24]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[25]  T. Allan,et al.  European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). , 2000, European heart journal.

[26]  S. Yusuf,et al.  Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .

[27]  S. Kuribayashi,et al.  Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. , 1998, Journal of the American College of Cardiology.

[28]  M A Konstam,et al.  Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. , 1995, Journal of cardiac failure.

[29]  J. Bett,et al.  Consensus opinion and observer accuracy in electrocardiography with reference to coronary arteriographic information. , 1976, Australian and New Zealand journal of medicine.